TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$35.8K
Year ended 2025-12-31
$359.7K2021-12-31: -$365.4K2022-12-31: -$321.4K2023-12-31: $359.7K2024-12-31: $312.0K2025-12-31: -$35.8K-$35.8K
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$35.8Kn/m2026-05-15, From 2025-01-01
2024-12-31$312.0K-13.3%2026-05-15, From 2024-01-01
2023-12-31$359.7Kn/m2026-05-15, From 2023-01-01
2022-12-31-$321.4Kn/m2025-09-23, From 2022-01-01
2021-12-31-$365.4Kn/a2025-09-23, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
TFA Therapeutics, Inc. (RAJAF)2025-12-31-$35.8Kn/m
Adia Med, Inc. (ADIA)2025-12-31-$179.2Kn/m
Target Group Inc. (CBDY)2025-12-31-$842.4Kn/m
Healthy Extracts Inc. (HYEX)2025-12-31$165.5K-41.3%
China Foods Holdings Ltd. (CFOO)2025-12-31-$389.3Kn/m
Nutra Pharma Corp (NPHC)2025-12-31-$1.16Mn/m
Functional Brands Inc. (MEHA)2025-12-31-$1.27Mn/m
Bon Natural Life Ltd (BON)2025-09-30$141.1Kn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$5.78Mn/m

Compare RAJAF, ADIA, CBDY, HYEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗